Medroxyprogesterone
CAS No. 520-85-4
Medroxyprogesterone( —— )
Catalog No. M19809 CAS No. 520-85-4
Medroxyprogesterone is used in the treatment of renal carcinoma. It is a synthetic progestational hormone used in veterinary practice as an estrus regulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 30 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 500MG | 133 | In Stock |
|
| 1G | 177 | In Stock |
|
Biological Information
-
Product NameMedroxyprogesterone
-
NoteResearch use only, not for human use.
-
Brief DescriptionMedroxyprogesterone is used in the treatment of renal carcinoma. It is a synthetic progestational hormone used in veterinary practice as an estrus regulator.
-
DescriptionMedroxyprogesterone is used in the treatment of renal carcinoma. It is a synthetic progestational hormone used in veterinary practice as an estrus regulator.
-
In VitroCell Proliferation Assay Cell Line:T47D Concentration:10 nM Incubation Time:24 h, 48 h, 72h Result:Increased the number of cells at 48 h.Western Blot Analysis Cell Line:T47D Concentration:10 nM Incubation Time:4 h Result:Induced the expression of Cyclin D1 protein.RT-PCR Cell Line:HUVECs Concentration:100 nM Incubation Time:24 h Result:Increased mRNA and protein expression of adhesion molecules.
-
In VivoAnimal Model:ApoE-/- mice model Dosage:27.7 μg/day Administration:s.c.Result:Reduced atherosclerotic plaque and increased thrombosis.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorEstrogen/progestogen Receptor
-
Research AreaInflammation/Immunology
-
IndicationAutoimmune haemolytic anaemia; Crohn's disease; Idiopathic thrombocytopenic purpura; Ulcerative colitis
Chemical Information
-
CAS Number520-85-4
-
Formula Weight344.49
-
Molecular FormulaC22H32O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:197.4 mM
-
SMILESC[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12
-
Chemical NamePregn-4-ene-320-dione 17-hydroxy-6-alpha-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Okojie A K Oyekunle O A . Depo-Provera effects on Wistar rat performance in the Y-maze.[J]. Metabolic Brain Disease 2014 29(2):529-31.
molnova catalog
related products
-
Zindoxifene
Zindoxifene (D 16726) is an anti-estrogenic compound with antitumor activity that can be used in studies of breast and prostate cancer.
-
GDC-0927 R-form
GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD).
-
4',7-Dimethoxyisofla...
4', 7-dimethoxyisoflavone, a kind of isoflavonoids, showed inhibitory effects on rat prostate testosterone 5α-reductase.
Cart
sales@molnova.com